This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
Save the dateMarch 17–19, 2025 | Milan, Italy

Nick Dunscombe
VP, Head of New Product Planning, Astellas Pharma Inc. at Astellas Global


Nick Dunscombe is Vice President and Global Head of New Product Planning at Astellas, based in Manchester, UK. He has responsibility for developing the commercial strategy for all early assets in Astellas’ portfolio – this covers a broad portfolio including cell therapy, gene therapy, immuno-oncology and mitochondrial disease. In addition to supporting the in-house portfolio, he also supports externalization activities including partnerships and acquisitions.

Prior to joining Astellas, Nick worked for AstraZeneca for 29 years. In this time, he held a number of roles across Commercial, Development and Business Development, and across multiple geographies. His latter role at AstraZeneca was the Global Head of Alliance, Integration and Divestment, where he helped to build an in-house capability that implemented numerous large and small integrations and divestments.

Agenda Sessions

  • Perspectives for partnering success: communicating commercial appeal of early-stage assets